Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction.
about
Col4a1 mutations cause progressive retinal neovascular defects and retinopathyCharacterization of a spontaneous retinal neovascular mouse modelQuantitative spatial and temporal analysis of fluorescein angiography dynamics in the eyeEfficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy.Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice.Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases.Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism.A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration.Animal models of ocular angiogenesis: from development to pathologies.A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model.Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.A convenient protocol for establishing a human cell culture model of the outer retinaSpontaneous Posterior Segment Vascular Disease Phenotype of a Mouse Model, rnv3, Is Dependent on the Crb1rd8 AlleleHuman Vascular Endothelial Growth Factor A Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration
P2860
Q27303061-E17A19B8-2DBA-4FED-BB33-3C7E96C4C8C9Q27312714-21372CB4-803C-4305-A8FB-C5194DE33FA8Q27333956-859F6592-476B-44C6-93E5-31656FEF997AQ33791592-4EF910D2-6E53-4DEB-92A3-FFE6EA867C97Q35688161-6AF9466A-C606-4553-B7ED-CAD36CE92721Q35696092-55B3195C-CD40-4864-91DF-0D09EB93E12FQ36164238-A0888091-23A6-4827-860C-A75A5A472CF9Q37030276-362F6A17-6514-4D5F-ACE0-D8EF7D40E901Q38663964-F9989C4F-6070-4525-8C23-5DF98E7A8B6FQ39455385-5FD0B57C-9BA9-450A-9A3F-75CA36FEF9D7Q41463688-8D714E45-29FE-47E8-86EC-72EF92B70CCEQ49509910-6B79F659-1A80-4266-86C4-F295CE097FEEQ57139160-5761FF65-A94F-4D9A-B1CA-525060DEBCDEQ58125198-7E71D408-59B0-4F7D-8827-30408F5C6ADAQ58779270-B2E74423-1EF7-4106-B6D9-AD93201BAFA1
P2860
Spontaneous CNV in a novel mutant mouse is associated with early VEGF-A-driven angiogenesis and late-stage focal edema, neural cell loss, and dysfunction.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Spontaneous CNV in a novel mut ...... al cell loss, and dysfunction.
@ast
Spontaneous CNV in a novel mut ...... al cell loss, and dysfunction.
@en
type
label
Spontaneous CNV in a novel mut ...... al cell loss, and dysfunction.
@ast
Spontaneous CNV in a novel mut ...... al cell loss, and dysfunction.
@en
prefLabel
Spontaneous CNV in a novel mut ...... al cell loss, and dysfunction.
@ast
Spontaneous CNV in a novel mut ...... al cell loss, and dysfunction.
@en
P2093
P2860
P356
P1476
Spontaneous CNV in a novel mut ...... ral cell loss, and dysfunction
@en
P2093
Anthony P Adamis
Brett Hosking
David T Shima
Kanako Izumi-Nagai
Norihiro Nagai
Pete Lundh von Leithner
Peter Adamson
Richard H Foxton
P2860
P304
P356
10.1167/IOVS.14-13989
P407
P577
2014-05-20T00:00:00Z